Additional file 1 of Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

Troiani, Vanessa; Crist, Richard C.; Doyle, Glenn A.; Ferraro, Thomas N.; Beiler, Donielle; Ranck, Stephanie; McBryan, Kortney; Jarvis, Margaret A.; Barbour, Jordan S.; Han, John J.; Ness, Ryan J.; Berrettini, Wade H.; Robishaw, Janet D.

doi:10.6084/m9.figshare.16879994.v1

12920_2021_1100_MOESM1_ESM.docx (14.46 kB)

Additional file 1 of Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

journal contribution

posted on 2021-10-27, 03:26 authored by Vanessa Troiani, Richard C. Crist, Glenn A. Doyle, Thomas N. Ferraro, Donielle Beiler, Stephanie Ranck, Kortney McBryan, Margaret A. Jarvis, Jordan S. Barbour, John J. Han, Ryan J. Ness, Wade H. Berrettini, Janet D. Robishaw

Additional file 1. Instructions and Survey Questions for DSM self-report scale (e.g. Fig. 1). Questions and scoring procedure for adapting DSM questions for opioid use disorder into a self-report format.

Funding

national institute on drug abuse pennsylvania department of health

History

Usage metrics

Keywords

Opioid use disorder (OUD)Genetics Addiction Substance misuse

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 1 of Genetics and prescription opioid use (GaPO): study design for consenting a cohort from an existing biobank to identify clinical and genetic factors influencing prescription opioid use and abuse

Funding

national institute on drug abuse pennsylvania department of health

History

Usage metrics

Categories

Keywords

Licence

Exports